Triple-negative breast cancer (TNBC) is a breast cancer subtype as defined by the lack of estrogen receptor (ER) and progesterone receptor (PR), as well as human epidermal growth factor receptor-2 (HER-2) expressions. Here, ESR1 is linked to triple-negative breast carcinoma.